** Shares of medical devices maker Nanosonics NAN.AX fall 4.3% to A$4.64
** Bell Potter forecasts additional A$2.5 million ($1.59 million) to co's costs in FY26 due to U.S. tariffs on Australia
** Also sees co's new 'CORIS' devices to have minimal contribution to revenue in FY26
** Downgrades FY26 and FY27 earnings by 9%; reduces PT to A$4.05 from A$4.06
** Three analysts rate the stock "buy", 4 "hold" and 2 "sell"; their median PT is A$4.78 – LSEG data
** Stock trims YTD gains to 52.8%
($1 = 1.5726 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.